Brief: Boehringer Ingelheim And Biomx Collaborate To Discover Inflammatory Bowel Disease Microbiome Biomarkers

Biomx

28/06/2022 11:34

June 28 (Reuters) - Biomx Inc  PHGE.A :
    * BOEHRINGER INGELHEIM AND BIOMX COLLABORATE TO DISCOVER
INFLAMMATORY BOWEL DISEASE MICROBIOME BIOMARKERS
    * BIOMX INC - TERMS OF COLLABORATION ENTITLE BIOMX TO
RESEARCH
PAYMENTS
    * BIOMX - TERMS OF COLLABORATION INCLUDE OPTION FOR
BOEHRINGER
INGELHEIM TO NEGOTIATE AN EXCLUSIVE RIGHT TO BIOMARKERS
DISCOVERED UNDER COLLABORATION
    * BIOMX INC - BIOMX RETAINS RIGHT TO UTILIZE BIOMARKERS AS
COMPANION DIAGNOSTICS FOR PHAGE THERAPY

Source text for Eikon:  ID:nBw3VyLQha 
Further company coverage:  PHGE.A 

 ((Reuters.Briefs@thomsonreuters.com;))